TY - JOUR T1 - Telemedicine versus standard care for inflammatory bowel disease JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 113 LP - 113 DO - 10.1136/dtb.2017.10.0536 VL - 55 IS - 10 A2 - , Y1 - 2017/10/01 UR - http://dtb.bmj.com/content/55/10/113.1.abstract N2 - A randomised trial based in four hospitals in the Netherlands has compared a telemedicine system for inflammatory bowel disease (IBD) with standard care.1The system assessed in the study was myIBDCoach, which was developed to work for all subtypes of IBD. It includes monthly monitoring modules, which contain questions on disease activity, medication use, treatment adherence, treatment satisfaction, adverse effects (including infections), factors affecting disease (e.g. nutritional status, smoking, stress) and patient-reported outcome … ER -